BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8330398)

  • 1. Enzyme immunoassay of beta-hexosaminidase A and B in serum: carrier detection of GM2-gangliosidoses, and equivalence of enzyme activity and enzyme protein reactivity.
    Isaksson A; Hultberg B; Masson P; Landels E; Fensom A
    Clin Chem; 1993 Jul; 39(7):1412-5. PubMed ID: 8330398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual thermolability properties of leukocyte beta-hexosaminidase: implications in screening for carriers of Tay-Sachs disease.
    Prence EM; Natowicz MR; Zalewski I
    Clin Chem; 1993 Sep; 39(9):1811-4. PubMed ID: 8375052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases.
    Maret A; Salvayre R; Negre A; Bes JC; Douste-Blazy L
    Biol Cell; 1985; 53(3):293-6. PubMed ID: 2990625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sandhoff disease heterozygote detection: a component of population screening for Tay-Sachs disease carriers. I. Statistical methods.
    Cantor RM; Lim JS; Roy C; Kaback MM
    Am J Hum Genet; 1985 Sep; 37(5):912-21. PubMed ID: 4050790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-hexosaminidase in cultured normal and mutant human fibroblasts: an immunohistochemical and biochemical investigation.
    Elsafi ME; Elbashir MI; Hultberg B; Isaksson A; Hägerstrand I; Stenram U
    Scand J Clin Lab Invest; 1991 Dec; 51(8):711-4. PubMed ID: 1839650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.
    Mark BL; Mahuran DJ; Cherney MM; Zhao D; Knapp S; James MN
    J Mol Biol; 2003 Apr; 327(5):1093-109. PubMed ID: 12662933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tay-Sachs and Sandhoff diseases: enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards.
    Chamoles NA; Blanco M; Gaggioli D; Casentini C
    Clin Chim Acta; 2002 Apr; 318(1-2):133-7. PubMed ID: 11880123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoassay of beta-hexosaminidase isoenzymes in serum in patients with raised total activities.
    Isaksson A; Hultberg B
    Clin Chim Acta; 1989 Aug; 183(2):155-62. PubMed ID: 2529064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new form of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts.
    Hechtman P; Khoo K; Isaacs C
    Clin Genet; 1983 Sep; 24(3):206-15. PubMed ID: 6226462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
    Bayleran J; Hechtman P; Saray W
    Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual thermolability properties of beta-hexosaminidase: studies of enzyme from cultured cells and clinical implications.
    Prence EM; Zalewski I; Natowicz MR
    Am J Med Genet; 1996 Nov; 65(4):320-4. PubMed ID: 8923943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Tay-Sachs disease carriers among individuals with thermolabile hexosaminidase B.
    Peleg L; Goldman B
    Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):65-9. PubMed ID: 8003579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common HEXB polymorphisms reduce serum HexA and HexB enzymatic activities, potentially masking Tay-Sachs disease carrier identification.
    Vallance H; Morris TJ; Coulter-Mackie M; Lim-Steele J; Kaback M
    Mol Genet Metab; 2006 Feb; 87(2):122-7. PubMed ID: 16352452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum beta-hexosaminidases in pregnancy.
    Lowden JA
    Clin Chim Acta; 1979 May; 93(3):409-17. PubMed ID: 445857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay and heat denaturation enzyme assay for the detection of Tay-sachs heterozygotes during pregnancy.
    Nguyen C; Gold RJ; Mahuran D; Lowden JA
    Clin Chim Acta; 1981 Jun; 113(1):13-25. PubMed ID: 6453673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory diagnosis of canine GM2-gangliosidosis using blood and cerebrospinal fluid.
    Yamato O; Satoh H; Matsuki N; Ono K; Yamasaki M; Maede Y
    J Vet Diagn Invest; 2004 Jan; 16(1):39-44. PubMed ID: 14974845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of candidate active site residues in lysosomal beta-hexosaminidase A.
    Fernandes MJ; Yew S; Leclerc D; Henrissat B; Vorgias CE; Gravel RA; Hechtman P; Kaplan F
    J Biol Chem; 1997 Jan; 272(2):814-20. PubMed ID: 8995368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatofocusing coupled with automated assay for beta-hexosaminidase isoenzymes in GM2 gangliosidosis.
    Orlacchio A; Maffei C; Emiliani C; Coppa GV; Felici L
    Experientia; 1985 Apr; 41(4):525-7. PubMed ID: 3157597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.
    Strasberg PM; Clarke JT
    Clin Chem; 1992 Nov; 38(11):2249-55. PubMed ID: 1424119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
    Christopher R; Rangaswamy GR; Shetty KT
    Indian J Pediatr; 1995; 62(4):479-83. PubMed ID: 10829909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.